Skip to main content
Top
Published in: Annals of Surgical Oncology 12/2011

01-11-2011 | Melanomas

What is the Significance of the In Transit or Interval Sentinel Node in Melanoma?

Authors: Jonathan S. Zager, MD, Christopher A. Puleo, PA-C, Vernon K. Sondak, MD

Published in: Annals of Surgical Oncology | Issue 12/2011

Login to get access

Excerpt

The advent of radionuclide lymphoscintigraphy as part of sentinel lymph node biopsy procedures for melanoma led to changes in our understanding of lymphatic anatomy, but the clinical significance of these changes are still undefined. Although it quickly became clear that primary melanomas frequently drained to lymph nodes outside of the traditional “major” basins (cervical, axillary, and ilioinguinal), it has been less clear what to do about these nodes—or even what to call them. Definitions of the three major nodal basins and their subdivisions are fairly standardized: the axillary basin consists of levels I–III; the ilioinguinal basin can be broken down into inguinofemoral, external, and common iliac and obturator nodes; and the cervical basin consists of levels I–VI. Whether to include occipital, pre- and postauricular, and parotid nodes as part of the cervical basin has not been totally standardized, but it seems reasonable to include them. For the extremities, epitrochlear and popliteal nodes are considered “minor” nodal basins, and internal mammary nodes often are but not always classified similarly (but probably should be). Beyond that, there is little standardization about what to call the many nodes that can be found in small numbers throughout the body, especially in the soft tissues of the posterior and lateral trunk, which occasionally serve as primary draining nodes for the skin. …
Literature
1.
go back to reference Verwer N, Scolyer R, Uren R, et al. Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma. Ann Surg Oncol. 2011; doi:10.1245/s10434-011-1988-5. Verwer N, Scolyer R, Uren R, et al. Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma. Ann Surg Oncol. 2011; doi:10.​1245/​s10434-011-1988-5.
2.
go back to reference Leong SPL, Kim J, Ross M, et al. A phase 2 study of 99mTc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011;18:961–9.PubMedCrossRef Leong SPL, Kim J, Ross M, et al. A phase 2 study of 99mTc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011;18:961–9.PubMedCrossRef
3.
go back to reference Carling T, Pan D, Ariyan S, Narayan D, Truini C. Diagnosis and treatment of interval sentinel lymph nodes in patients with cutaneous melanoma. Plast Reconstr Surg. 2007;119:907–13.PubMedCrossRef Carling T, Pan D, Ariyan S, Narayan D, Truini C. Diagnosis and treatment of interval sentinel lymph nodes in patients with cutaneous melanoma. Plast Reconstr Surg. 2007;119:907–13.PubMedCrossRef
4.
go back to reference Vidal-Sicart S, Pons F, Fuertes S, et al. Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging. 2004;31:945–9.PubMedCrossRef Vidal-Sicart S, Pons F, Fuertes S, et al. Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging. 2004;31:945–9.PubMedCrossRef
5.
go back to reference Uren R, Howman-Giles R, Thompson JF, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 2000;135:1168–72.PubMedCrossRef Uren R, Howman-Giles R, Thompson JF, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 2000;135:1168–72.PubMedCrossRef
6.
go back to reference McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543–7.PubMedCrossRef McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543–7.PubMedCrossRef
7.
go back to reference Puleo CA, Sondak VK, Cruse CW, Berman CG, Zager JS, Messina JL. Melanoma sentinel node metastases in non-traditional sites. In: Proceedings fifth biennial international sentinel node society conference, November 1–4, 2006; p. 127. Puleo CA, Sondak VK, Cruse CW, Berman CG, Zager JS, Messina JL. Melanoma sentinel node metastases in non-traditional sites. In: Proceedings fifth biennial international sentinel node society conference, November 1–4, 2006; p. 127.
8.
go back to reference Hunt JA, Thompson JF, Uren RF, Howman-Giles R, Harman CR. Epitrochlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol. 1998;5:248–52.PubMedCrossRef Hunt JA, Thompson JF, Uren RF, Howman-Giles R, Harman CR. Epitrochlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol. 1998;5:248–52.PubMedCrossRef
9.
go back to reference Thompson JF, Hunt JA, Culjak G, Uren RF, Howman-Giles R, Harman CR. Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol. 2000;26:172–6.PubMedCrossRef Thompson JF, Hunt JA, Culjak G, Uren RF, Howman-Giles R, Harman CR. Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol. 2000;26:172–6.PubMedCrossRef
Metadata
Title
What is the Significance of the In Transit or Interval Sentinel Node in Melanoma?
Authors
Jonathan S. Zager, MD
Christopher A. Puleo, PA-C
Vernon K. Sondak, MD
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 12/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1996-5

Other articles of this Issue 12/2011

Annals of Surgical Oncology 12/2011 Go to the issue